TOBIE HALPIN-HIGMAN: Open Payments
NPI 1295976165 · BURIEN, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 16 payments from 10 companies in 2025. Trend: 2023 $34 · 2024 $0 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 4 | $80 |
| PFIZER INC. | 2 | $45 |
| ABBVIE INC. | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
Products named: VOQUEZNA, XELJANZ, TREMFYA, SKYRIZI, IQIRVO, XIFAXAN, INJECTAFER, REZDIFFRA.
Industry payments across WA — which companies pay providers there.
